Efficacy and Safety of Lactobacillus Plantarum C29-Fermented Soybean (DW2009) in Individuals with Mild Cognitive Impairment: A 12-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Yun-Ha Hwang, Shinwon Park, Jong-Woo Paik, Soo-Wan Chae, Dong-Hyun Kim, Doc-Gyun Jeong, Eunji Ha, Myeongju Kim, Gahae Hong, Soo-Hyun Park, Su-Jin Jung, Sang-Min Lee, Kyu-Heum Na, Jungyoon Kim, Young-Chul Chung, Yun-Ha Hwang, Shinwon Park, Jong-Woo Paik, Soo-Wan Chae, Dong-Hyun Kim, Doc-Gyun Jeong, Eunji Ha, Myeongju Kim, Gahae Hong, Soo-Hyun Park, Su-Jin Jung, Sang-Min Lee, Kyu-Heum Na, Jungyoon Kim, Young-Chul Chung

Abstract

Early intervention using dietary supplements may be effective in alleviating cognitive impairment among individuals with mild cognitive impairment (MCI). This study investigated the efficacy and safety of Lactobacillus plantarum C29-fermented soybean (DW2009) as a nutritional supplement for cognitive enhancement. One hundred individuals with MCI were randomly assigned to take DW2009 (800 mg/day, n = 50) or placebo (800 mg/day, n = 50) for 12 weeks. The primary outcome measure was change in the composite score of cognitive functions related to memory and attention, measured by computerized neurocognitive function tests. Associations between changes in serum brain-derived neurotrophic factor (BDNF) levels and cognitive performance for each treatment group were evaluated. Compared to the placebo group, the DW2009 group showed greater improvements in the combined cognitive functions (z = 2.36, p for interaction = 0.02), especially in the attention domain (z = 2.34, p for interaction = 0.02). Cognitive improvement was associated with increased serum BDNF levels after consumption of DW2009 (t = 2.83, p = 0.007). The results of this clinical trial suggest that DW2009 can be safely administered to enhance cognitive function in individuals with MCI. Increased serum BDNF levels after administering DW2009 may provide preliminary insight into the underlying effects of cognitive improvement, which suggests the importance of the gut-brain axis in ameliorating cognitive deficits in MCI.

Keywords: Brain-derived neurotrophic factor; Cognitive impairment; Lactobacillus plantarum C29-fermented soybean (DW2009); Mild cognitive impairment.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Screening, randomization, and allocation of participants to the DW2009 or placebo groups.
Figure 2
Figure 2
Differences in changes in composite z scores of each cognitive domain and combined cognitive function between the placebo-treated and DW2009-treated groups. Error bars indicate standard errors.
Figure 3
Figure 3
Association between change in brain-derived neurotrophic factor (BDNF) levels and combined cognitive function in (a) DW2009 treatment group and (b) placebo group. Composite z scores for the combined cognitive function were calculated by averaging z scores of the measured cognitive domains (attention, working memory, and verbal memory).

References

    1. Gauthier S., Reisberg B., Zaudig M., Petersen R.C., Ritchie K., Broich K., Belleville S., Brodaty H., Bennett D., Chertkow H., et al. Mild cognitive impairment. Lancet. 2006;367:1262–1270. doi: 10.1016/S0140-6736(06)68542-5.
    1. Petersen R.C. Clinical practice. Mild cognitive impairment. N. Engl. J. Med. 2011;364:2227–2234. doi: 10.1056/NEJMcp0910237.
    1. Panza F., D’Introno A., Colacicco A.M., Capurso C., Del Parigi A., Caselli R.J., Pilotto A., Argentieri G., Scapicchio P.L., Scafato E., et al. Current epidemiology of mild cognitive impairment and other predementia syndromes. Am. J. Geriatr. Psychiatry. 2005;13:633–644. doi: 10.1097/00019442-200508000-00002.
    1. Boyle P., Wilson R., Aggarwal N., Tang Y., Bennett D. Mild cognitive impairment: Risk of Alzheimer disease and rate of cognitive decline. Neurology. 2006;67:441–445. doi: 10.1212/01.wnl.0000228244.10416.20.
    1. Akbari E., Asemi Z., Daneshvar Kakhaki R., Bahmani F., Kouchaki E., Tamtaji O.R., Hamidi G.A., Salami M. Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: A randomized, double-blind and controlled trial. Front. Aging Neurosci. 2016;8:1–8. doi: 10.3389/fnagi.2016.00256.
    1. Jung I.H., Jung M.A., Kim E.J., Han M., Kim D.H. Lactobacillus pentosus var. plantarum C29 protects scopolamine-induced memory deficit in mice. J. Appl. Microbiol. 2012;113:1498–1506. doi: 10.1111/j.1365-2672.2012.05437.x.
    1. Jeong J.J., Woo J.Y., Kim K.A., Han M., Kim D.H. Lactobacillus pentosus var. plantarum C29 ameliorates age-dependent memory impairment in Fischer 344 rats. Lett. Appl. Microbiol. 2015;60:307–314. doi: 10.1111/lam.12393.
    1. Lee H.J., Jeong J.J., Han M.J., Kim D.H. Lactobacillus plantarum C29 Alleviates TNBS-Induced Memory Impairment in Mice. J. Microbiol. Biotechnol. 2018;28:175–179. doi: 10.4014/jmb.1709.09042.
    1. File S.E., Jarrett N., Fluck E., Duffy R., Casey K., Wiseman H. Eating soya improves human memory. Psychopharmacology. 2001;157:430–436. doi: 10.1007/s002130100845.
    1. Hong S.-W., Heo H., Yang J.-h., Han M., Kim D.-H., Kwon Y.K. Soyasaponin I improved neuroprotection and regeneration in memory deficient model rats. PLoS ONE. 2013;8:1–17. doi: 10.1371/journal.pone.0081556.
    1. Xi Y.-D., Li X.-Y., Ding J., Yu H.-L., Ma W.-W., Yuan L.-H., Wu J., Xiao R. Soy isoflavone alleviates Aβ1-42-induced impairment of learning and memory ability through the regulation of RAGE/LRP-1 in neuronal and vascular tissue. Curr. Neurovasc. Res. 2013;10:144–156. doi: 10.2174/1567202611310020007.
    1. Sirilun S., Sivamaruthi B.S., Kesika P., Peerajan S., Chaiyasut C. Lactic acid bacteria mediated fermented soybean as a potent nutraceutical candidate. Asian Pac. J. Trop. Biomed. 2017;7:930–936. doi: 10.1016/j.apjtb.2017.09.007.
    1. Lee H.J., Hwang Y.H., Kim D.H. Lactobacillus plantarum C29-fermented soybean (DW2009) alleviates memory impairment in 5XFAD transgenic mice by regulating microglia activation and gut microbiota composition. Mol. Nutr. Food Res. 2018;62:1–7. doi: 10.1002/mnfr.201800359.
    1. Yanhong O., Chandra M., Venkatesh D. Mild cognitive impairment in adult: A neuropsychological review. Ann. Indian Acad. Neur. 2013;16:310–318. doi: 10.4103/0972-2327.116907.
    1. Saunders N.L., Summers M.J. Attention and working memory deficits in mild cognitive impairment. J. Clin. Exp. Neuropsychol. 2010;32:350–357. doi: 10.1080/13803390903042379.
    1. Yoo D.-H., Kim D.-H. Lactobacillus pentosus var. plantarum C29 increases the protective effect of soybean against scopolamine-induced memory impairment in mice. Int. J. Food Sci. Nutr. 2015;66:912–918. doi: 10.3109/09637486.2015.1064865.
    1. Ha K.S., Kwon J.S., Lyoo I.K., Kong S.W., Lee D.W., Youn T. Development and standardization process, and factor analysis of the computerized cognitive function test system for Korean adults. J. Korean Neuropsychiatr. Assoc. 2002;41:551–562.
    1. Kwon J.S., Lyoo I.K., Hong K.S., Yeon B.K., Ha K.S. Development and standardization of the computerized memory assessment for Korean adults. J. Korean Neuropsychiatr. Assoc. 2002;41:347–362.
    1. Ha K.S., Kwon J.S., Lyoo I.K. Development and standardization of the computerized attention assessment for Korean adults. J. Korean Neuropsychiatr. Assoc. 2002;41:335–346.
    1. Mattson M.P., Maudsley S., Martin B. BDNF and 5-HT: A dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 2004;27:589–594. doi: 10.1016/j.tins.2004.08.001.
    1. Bekinschtein P., Cammarota M., Igaz L.M., Bevilaqua L.R., Izquierdo I., Medina J.H. Persistence of long-term memory storage requires a late protein synthesis-and BDNF-dependent phase in the hippocampus. Neuron. 2007;53:261–277. doi: 10.1016/j.neuron.2006.11.025.
    1. Lu B., Chow A. Neurotrophins and hippocampal synaptic transmission and plasticity. J. Neurosci. Res. 1999;58:76–87. doi: 10.1002/(SICI)1097-4547(19991001)58:1<76::AID-JNR8>;2-0.
    1. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., Kolbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation? J. Exp. Med. 1999;189:865–870. doi: 10.1084/jem.189.5.865.
    1. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003;112:257–269. doi: 10.1016/S0092-8674(03)00035-7.
    1. Rybakowski J., Borkowska A., Skibinska M., Hauser J. Illness-specific association of val66met BDNF polymorphism with performance on Wisconsin Card Sorting Test in bipolar mood disorder. Mol. Psychiatry. 2006;11:122–124. doi: 10.1038/sj.mp.4001765.
    1. Laske C., Stransky E., Leyhe T., Eschweiler G., Wittorf A., Richartz E., Bartels M., Buchkremer G., Schott K. Stage-dependent BDNF serum concentrations in Alzheimer’s disease. J. Neural Transm. 2006;113:1217–1224. doi: 10.1007/s00702-005-0397-y.
    1. Shimada H., Makizako H., Yoshida D., Tsutsumimoto K., Anan Y., Uemura K., Lee S., Park H., Suzuki T. A large, cross-sectional observational study of serum BDNF, cognitive function, and mild cognitive impairment in the elderly. Front. Aging Neurosci. 2014;6:1–9. doi: 10.3389/fnagi.2014.00069.
    1. Dinan T.G., Stilling R.M., Stanton C., Cryan J.F. Collective unconscious: How gut microbes shape human behavior. J. Psychiatr. Res. 2015;63:1–9. doi: 10.1016/j.jpsychires.2015.02.021.
    1. de J. R. De-Paula V., Forlenza A.S., Forlenza O.V. Relevance of gut microbiota in cognition, behaviour and Alzheimer’s disease. Pharmacol. Res. 2018;136:29–34. doi: 10.1016/j.phrs.2018.07.007.
    1. Tan J., McKenzie C., Potamitis M., Thorburn A.N., Mackay C.R., Macia L. The Role of Short-Chain Fatty Acids in Health and Disease. Adv. Immunol. 2014;121:91–119. doi: 10.1016/B978-0-12-800100-4.00003-9.
    1. Lee H.-J., Lim S.-M., Ko D.-B., Jeong J.-J., Hwang Y.-H., Kim D.-H. Soyasapogenol B and genistein attenuate lipopolysaccharide-induced memory impairment in mice by the modulation of NF-κB-mediated BDNF expression. J. Agric. Food Chem. 2017;65:6877–6885. doi: 10.1021/acs.jafc.7b02569.
    1. Flint H.J., Scott K.P., Louis P., Duncan S.H. The role of the gut microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepatol. 2012;9:577–589. doi: 10.1038/nrgastro.2012.156.
    1. Martí J.M., Martínez-Martínez D., Rubio T., Gracia C., Peña M., Latorre A., Moya A., Garay C.P. Health and disease imprinted in the time variability of the human microbiome. mSystems. 2017;2:1–16. doi: 10.1128/mSystems.00144-16.
    1. Salminen S., von Wright A., Morelli L., Marteau P., Brassart D., de Vos W.M., Fondén R., Saxelin M., Collins K., Mogensen G. Demonstration of safety of probiotics—A review. Int. J. Food Microbiol. 1998;44:93–106. doi: 10.1016/S0168-1605(98)00128-7.
    1. Cryan J.F., Dinan T.G. Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 2012;13:701–712. doi: 10.1038/nrn3346.
    1. Dinan T.G., Cryan J.F. Brain-gut-microbiota axis and mental health. Psychosom. Med. 2017;79:920–926. doi: 10.1097/PSY.0000000000000519.
    1. Krikorian R., Shidler M.D., Nash T.A., Kalt W., Vinqvist-Tymchuk M.R., Shukitt-Hale B., Joseph J.A. Blueberry supplementation improves memory in older adults. J. Agric. Food Chem. 2010;58:3996–4000. doi: 10.1021/jf9029332.
    1. Desideri G., Kwik-Uribe C., Grassi D., Necozione S., Ghiadoni L., Mastroiacovo D., Raffaele A., Ferri L., Bocale R., Lechiara M.C., et al. Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: The Cocoa, Cognition, and Aging (CoCoA) study. Hypertension. 2012;60:794–801. doi: 10.1161/HYPERTENSIONAHA.112.193060.
    1. Ito N., Saito H., Seki S., Ueda F., Asada T. Effects of composite supplement containing astaxanthin and sesamin on cognitive functions in people with mild cognitive impairment: A randomized, double-blind, placebo-controlled trial. J. Alzheimers Dis. 2018;62:1767–1775. doi: 10.3233/JAD-170969.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj